Arthrogryposis Market Report 2026

Arthrogryposis Market Overview

• Arthrogryposis market size has reached to $0.98 billion in 2025 • Expected to grow to $1.27 billion in 2030 at a compound annual growth rate (CAGR) of 5.2% • Growth Driver: Rising Prevalence Of Congenital Disorders Driving Growth In The Market • Market Trend: Advancements In Growth-Modulation Technologies Improve Orthopedic Management In Arthrogryposis • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Arthrogryposis Market?

Arthrogryposis refers to a group of congenital conditions characterized by multiple joint contractures, leading to stiffness and limited movement. It occurs due to reduced fetal movement in the womb, which can result from neurological, muscular, or connective tissue disorders. The main types of arthrogryposis are classic arthrogryposis, distal arthrogryposis, and amyoplasia. Classic arthrogryposis is a condition characterized by multiple joint contractures (stiffness or fixation) present at birth, often accompanied by muscle weakness and limited mobility. Treatment involves occupational therapy, physical therapy, surgery, imaging diagnostics, and CT scans. The disorder can affect children, adults, and the elderly, and treatment is distributed through various channels such as hospital pharmacies, retail pharmacies, online pharmacies, and other distribution channels.

What Is The Arthrogryposis Market Growth Forecast?

The arthrogryposis market size is expected to see strong growth in the next few years. It will grow to $1.27 billion in 2030 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to increasing investments in rare disease research, rising demand for personalized rehabilitation programs, expansion of early screening initiatives, growing focus on long-term quality of life improvement, increasing integration of advanced diagnostic technologies. Major trends in the forecast period include increasing focus on early diagnosis and intervention, rising adoption of multidisciplinary treatment approaches, growing use of advanced imaging diagnostics, expansion of long-term rehabilitation programs, enhanced supportive care strategies.

Global Arthrogryposis Market Segmentation

1) By Type: Classic Arthrogryposis, Distal Arthrogryposis, Amyoplasia 2) By Treatment Type: Occupational Therapists, Physical Therapy, Surgery, Imaging Diagnostics 3) By Patient Age: Children, Adults Subsegments: 1) By Classic Arthrogryposis: Multiple Joint Involvement, Flexion Contractures, Severe Muscle Weakness, Progressive Arthrogryposis, Intellectual Impairment 2) By Distal Arthrogryposis: Isolated Limb Involvement, Contractures of Hands and Feet, Distal Joint Contractures, Autosomal Dominant Inheritance 3) By Amyoplasia: Severe Limb Contractures, Muscle Hypotonia (low muscle tone), No Cognitive Impairment, Symmetric Joint Involvement, Lack Of Muscle Development In Affected Limbs

What Are The Drivers Of The Arthrogryposis Market?

The rising prevalence of congenital disorders is expected to propel the growth of the arthrogryposis market going forward. Congenital disorders are abnormalities, either structural or functional, that occur during fetal development and are present at birth. The increasing prevalence of congenital disorders can be attributed to factors such as advances in prenatal diagnostics, environmental exposures, genetic mutations, and lifestyle changes. Arthrogryposis helps in understanding congenital disorders by highlighting the role of fetal movement, genetic factors, and neuromuscular development in musculoskeletal abnormalities. For instance, in February 2023, according to the World Health Organization, a Switzerland-based intergovernmental organization, each year, approximately 240,000 newborns globally succumb to congenital disorders within the first 28 days of life. Additionally, congenital conditions contribute to an estimated 170,000 child fatalities between the ages of 1 month and 5 years. Therefore, the rising prevalence of congenital disorders is driving growth in the arthrogryposis industry. The rise in telehealth services is expected to propel the growth of the arthrogryposis market going forward. Telehealth services refer to the use of digital communication tools, such as video calls, phone calls, and online messaging, to provide healthcare services and consultations remotely, making it easier for patients to access medical care from home or other locations. Telehealth services are increasing due to their convenience, accessibility, and ability to reduce healthcare costs while improving patient access to care, especially in remote or underserved areas. Arthrogryposis benefits telehealth services by enabling remote consultations, early diagnosis, and continuous management of joint contractures, improving access to specialized care for patients with mobility challenges. For instance, in May 2024, according to the Australian Digital Health Agency, an Australia-based government organization, over 95,000 practitioners had utilized telehealth services, and 118.2 million telehealth services were offered to 18 million patients over the last two years. Therefore, the rise in telehealth services is driving growth in the arthrogryposis industry.

Key Players In The Global Arthrogryposis Market

Major companies operating in the arthrogryposis market are Boston Children’s Hospital, Seattle Children’s Hospital, Shriners Hospitals for Children, Texas Scottish Rite Hospital for Children, Gillette Children’s Specialty Healthcare, Cleveland Clinic, Johns Hopkins Hospital, Mayo Clinic, Children’s Hospital of Philadelphia, Nationwide Children’s Hospital, Children’s Healthcare of Atlanta, Nemours Children’s Health, Phoenix Children’s Hospital, Cincinnati Children’s Hospital Medical Center, St Jude Children’s Research Hospital, Rady Children’s Hospital San Diego, Children’s National Hospital, Great Ormond Street Hospital, SickKids Hospital Toronto, Royal Children’s Hospital Melbourne

Global Arthrogryposis Market Trends and Insights

Major companies operating in the arthrogryposis treatment market are focusing on developing advanced orthopedic solutions, such as guided-growth systems, to enhance deformity correction, reduce surgical burden, and support better functional outcomes in affected patients. Guided-growth systems enable controlled modulation of bone alignment during a child’s growth, helping clinicians gradually correct joint contractures with minimal tissue disruption. For instance, in June 2023, OrthoPediatrics Corp., a US-based pediatric orthopedic company, launched a growth modulation system featuring guided implant technology that provides precise intraoperative alignment control, minimally invasive implantation, patient-specific sizing options, compatibility with standard surgical instruments, and improved monitoring of growth progression. Designed to support targeted deformity correction, this technology offers clinicians a more controlled and less invasive approach to managing joint abnormalities commonly seen in arthrogryposis.

Regional Outlook

North America was the largest region in the arthrogryposis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Arthrogryposis Market?

The arthrogryposis market consists of revenues earned by entities by providing services such as medical diagnosis and consultation, surgical interventions, orthotic services, and pediatric care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Arthrogryposis Market Report 2026?

The arthrogryposis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the arthrogryposis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.